For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor ...

Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets.

It further said that the single-dose ampules are both bioequivalent and therapeutically equivalent to the reference listed ...

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...

The study analyzed blood samples of turkey vultures in southern California. Scientists make disturbing new discovery after ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

Anthos Therapeutics' abelacimab shows lower bleeding risk vs Xarelto in atrial fibrillation trial, with 62% reduction in ...